141 related articles for article (PubMed ID: 34515686)
1. Direct Reprogramming of Mouse Fibroblasts into Melanocytes.
Zhang YX; Liu LP; Jin M; Sun H; Zhang HL; Li YM
J Vis Exp; 2021 Aug; (174):. PubMed ID: 34515686
[TBL] [Abstract][Full Text] [Related]
2. Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors.
Yang R; Zheng Y; Li L; Liu S; Burrows M; Wei Z; Nace A; Herlyn M; Cui R; Guo W; Cotsarelis G; Xu X
Nat Commun; 2014 Dec; 5():5807. PubMed ID: 25510211
[TBL] [Abstract][Full Text] [Related]
3. Intelligent bioengineering in vitiligo treatment: transdermal protein transduction of melanocyte-lineage-specific genes.
Mou Y; Jiang X; Du Y; Xue L
Med Hypotheses; 2012 Dec; 79(6):786-9. PubMed ID: 22999738
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of neuregulin1 in the lesional skin of vitiligo patients.
Rani S; Kumari U; Bhardwaj S; Parsad D; Sharma VL; Kumar R
Int J Dermatol; 2019 Feb; 58(2):242-249. PubMed ID: 30074619
[TBL] [Abstract][Full Text] [Related]
5. The regenerative potential of autologous stem and somatic cells in vitiligo.
Chanteloube S; Debret R
Eur J Dermatol; 2024 Feb; 34(1):13-17. PubMed ID: 38557453
[TBL] [Abstract][Full Text] [Related]
6. A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.
Manga P; Sheyn D; Yang F; Sarangarajan R; Boissy RE
Am J Pathol; 2006 Nov; 169(5):1652-62. PubMed ID: 17071589
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of adipose-derived stem cells to functional CD105
Zavala G; Sandoval C; Meza D; Contreras R; Gubelin W; Khoury M
Stem Cell Res Ther; 2019 Aug; 10(1):249. PubMed ID: 31399041
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation.
Cario-André M; Pain C; Gauthier Y; Casoli V; Taieb A
Pigment Cell Res; 2006 Oct; 19(5):434-42. PubMed ID: 16965272
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
[TBL] [Abstract][Full Text] [Related]
10. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.
Birlea SA; Costin GE; Roop DR; Norris DA
Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168
[TBL] [Abstract][Full Text] [Related]
11. Involvement of non-melanocytic skin cells in vitiligo.
Bastonini E; Bellei B; Filoni A; Kovacs D; Iacovelli P; Picardo M
Exp Dermatol; 2019 Jun; 28(6):667-673. PubMed ID: 30582762
[TBL] [Abstract][Full Text] [Related]
12. Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.
Goldstein NB; Koster MI; Hoaglin LG; Wright MJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
Exp Dermatol; 2016 Oct; 25(10):805-11. PubMed ID: 27193292
[TBL] [Abstract][Full Text] [Related]
13. Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts.
Tsuchiyama K; Wakao S; Kuroda Y; Ogura F; Nojima M; Sawaya N; Yamasaki K; Aiba S; Dezawa M
J Invest Dermatol; 2013 Oct; 133(10):2425-2435. PubMed ID: 23563197
[TBL] [Abstract][Full Text] [Related]
14. Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligo.
Arora N; Siddiqui EM; Mehan S
Mol Cell Biochem; 2021 Mar; 476(3):1401-1409. PubMed ID: 33389492
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-17A receptor blocking in melanocyte survival: A strategic intervention against vitiligo.
Bhardwaj S; Bhatia A; Kumaran MS; Parsad D
Exp Dermatol; 2019 Jun; 28(6):682-689. PubMed ID: 30120811
[TBL] [Abstract][Full Text] [Related]
16. New insight into the role of exosomes in vitiligo.
Wong PM; Yang L; Yang L; Wu H; Li W; Ma X; Katayama I; Zhang H
Autoimmun Rev; 2020 Nov; 19(11):102664. PubMed ID: 32942029
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes.
Aguennouz M; Guarneri F; Oteri R; Polito F; Giuffrida R; Cannavò SP
J Dermatol Sci; 2021 Jan; 101(1):22-29. PubMed ID: 33176966
[TBL] [Abstract][Full Text] [Related]
18. The enigma and challenges of vitiligo pathophysiology and treatment.
Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide reduces melanin synthesis in vitiligo melanocytes by regulating autophagy.
Sun L; Sun J; Huo X; Feng Q; Li Y; Xie X; Geng S
Exp Dermatol; 2022 Oct; 31(10):1579-1585. PubMed ID: 35733278
[TBL] [Abstract][Full Text] [Related]
20. SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt/β-catenin signaling.
Zou DP; Chen YM; Zhang LZ; Yuan XH; Zhang YJ; Inggawati A; Kieu Nguyet PT; Gao TW; Chen J
Genes Dis; 2021 Sep; 8(5):677-688. PubMed ID: 34291139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
